Although YAP/TAZ are known to function as tumor suppressors in specific types of human cancers and the Hippo pathway can exert YAP/TAZ-independent functions in several cancer-related signaling events, the Hippo pathway LOF mutations identified here are defined based on its classic tumor suppressive role by inhibiting YAP and TAZ. This evidence concerns the gene YAP1 and cancer.